Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
123 participants
INTERVENTIONAL
2010-03-24
2013-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
NCT02108119
Probiotics for Irritable Bowel Syndrome
NCT00355810
Study of a Management Strategy of Functional Bowel Disordes Related to Irritable Bowel Syndrome (IBS) With a Mixture of 8 Microbiotic Strains
NCT05213910
Effect and Tolerance of a Probiotic-based Medical Device Administered to Patients With Irritable Bowel Syndrome
NCT04324658
The Efficacy of Single-strain Probiotics in Patients With Irritable Bowel Syndrome
NCT05064930
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The secondary purposes are to evaluate the effects of the intervention on:
* quality of life
* severity of fatigue, anxiety and depression
* levels of inflammatory markers in blood and tools
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Probiotics Excipients
Placebo
Placebo 2 gelules per days for 6 weeks
Lactibiane Tolerance
Probiotics combination
Lactibiane Tolerance
Probiotics combination 2 gelules per days during 6 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lactibiane Tolerance
Probiotics combination 2 gelules per days during 6 weeks
Placebo
Placebo 2 gelules per days for 6 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 150\< Francis Score \< 300
* HAD score inferior or egal to 25
Exclusion Criteria
* Use of probiotics or antibiotics last four weeks
* use of prohibited drugs
* bowel preparation for morphological examination last month
* pregnancy or lactation
* immundepressed or co-existing other serious illness or evolutive
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PiLeJe
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Piche Thierry, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu L'Archet 2
Nice, Alpes Maritimes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PiLeJe-LactiTol-0210
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.